Skip to main content
Cannara Biotech Inc. logo

Cannara Biotech Inc. — Investor Relations & Filings

Ticker · LOVE LEI · 875500MHKAAYHYVYZ941 TSXV Manufacturing
Open in API
Filings indexed 225 across all filing types
Latest filing 2025-11-24 Regulatory Filings
Country CA Canada
Listing TSXV LOVE

About Cannara Biotech Inc.

https://www.cannara.ca/

Cannara Biotech Inc. is a vertically integrated producer specializing in the cultivation and sale of premium-quality cannabis and cannabis-derivative products for the Canadian recreational and medical markets. The company operates state-of-the-art indoor cultivation facilities spanning over 1,650,000 square feet, designed for high efficiency, sustainability, and low-cost production, with an annualized output capacity of up to 100,000 kg. Cannara offers a wide range of products, including dried flowers, pre-rolls, and oils, marketed under brands such as TRIBAL, nugz, and ORCHID CBD. The company leverages advanced cultivation techniques and scale to deliver consistent, high-quality products at competitive value.

Recent filings

Filing Released Lang Actions
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a Form 13-501F1, which is a regulatory filing used by reporting issuers in Alberta, Canada, to calculate and report their participation fees based on market capitalization. It is a standard regulatory compliance document submitted to the Alberta Securities Commission. Since it does not fit into specific categories like financial reports, earnings releases, or shareholder communications, it falls under the 'Regulatory Filings' (RNS) category.
2025-11-24 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a Form 13-502F1, which is a regulatory filing required by the Ontario Securities Commission (OSC) for reporting issuers to calculate and pay their annual participation fees. It is not an annual report, earnings release, or any other operational document, but rather a specific regulatory compliance form. As it does not fit into the specific categories like 10-K, ER, or IR, it falls under the 'Regulatory Filings' (RNS) category.
2025-11-24 English
Annual information form - English.pdf
Audit Report / Information Classification · 1% confidence The document is explicitly titled 'Annual Information Form' for the fiscal year ended August 31, 2025. In Canadian securities regulation, an Annual Information Form (AIF) is a disclosure document that provides material information about a company and its business, including corporate structure, risk factors, and governance. While it is not the financial statements themselves (which would be in the 10-K or Annual Report), it is a core regulatory filing that accompanies the annual reporting package. Given the provided categories, '10-K' is the closest equivalent for a comprehensive annual regulatory disclosure document in this taxonomy. FY 2025
2025-11-24 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Audit Report / Information Classification · 1% confidence The document is a 'Form 52-109FV1', which is a Venture Issuer Basic Certificate used for the certification of annual filings. This document is a regulatory requirement that accompanies annual financial statements and MD&A to certify their accuracy. Since it is a standalone regulatory certification document rather than the annual report itself, and it does not fit into the other specific categories like 'Annual Report' (10-K) or 'Management Reports' (MDA), it is best classified as a Regulatory Filing. FY 2025
2025-11-24 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Audit Report / Information Classification · 1% confidence The document is a 'Form 52-109FV1', which is a Venture Issuer Basic Certificate used in Canadian securities regulation to certify annual filings. It is a standalone regulatory certification document that accompanies annual financial reports. Since it is a specific regulatory filing required by law to certify the accuracy of financial statements and does not fit into the categories of a full annual report, management report, or announcement, it is best classified as a Regulatory Filing (RNS). FY 2025
2025-11-24 English
Annual MD&A - English.pdf
Management Reports Classification · 1% confidence The document is explicitly titled 'MANAGEMENT DISCUSSION & ANALYSIS' for the year ended August 31, 2025. It contains detailed management commentary on financial performance, non-GAAP measures, and forward-looking statements, which is the standard content for an MD&A report. This document is a core component of the annual financial reporting package, distinct from a simple announcement or a full 10-K (which would include the audited financial statements themselves).
2025-11-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.